CS logo
small CS logo
Csongrad Megyei Egeszsegugyi Ellato Kozpont Hodmezovasarhely-Mako

Hodmezovasarhely, Hungary
Hospital in Hódmezővásárhely
Hódmezővásárhely, Dr. Imre József u. 9, 6800

About Csongrad Megyei Egeszsegugyi Ellato Kozpont Hodmezovasarhely-Mako


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Bayer
2
Boehringer Ingelheim
2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
2
Daiichi Sankyo, Inc.
1
Total Rows: 4

Clinical Trials at Csongrad Megyei Egeszsegugyi Ellato Kozpont Hodmezovasarhely-Mako


During the past decade, Csongrad Megyei Egeszsegugyi Ellato Kozpont Hodmezovasarhely-Mako conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years1100003300002200Started TrialsCompleted Trails201720182019202001234
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Vision Testing in Patients With Partial Seizures Receiving Either Lyrica or Placebo
2006-07-26
2020-02-04
Completed
187
A Safety, Efficacy and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric and Adult Subjects With Primary Generalized Tonic-Clonic (i.e., Grand Mal) Seizures.
2013-04-03
2019-02-20
Completed
219
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
2013-07-10
2018-01-18
Completed
6,991
Comparison of Two Doses of Edoxaban Using Different Tests (Assays) and Clinical Outcomes
2017-01-24
2018-10-09
Completed
607
Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone on Morbidity (Events Indicating Disease Worsening) & Mortality (Death Rate) in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%
2020-09-14
2024-09-13
Active, not recruiting
6,016
EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)
2020-12-16
2023-08-31
Active, not recruiting
6,522
Study to Investigate the Safety of a Drug Called Osocimab at Low and High Doses in Adult Patients With Kidney Failure Requiring Regular Hemodialysis
2020-08-28
2022-05-30
Completed
686

Rows per page:

1–7 of 7

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Csongrad Megyei Egeszsegugyi Ellato Kozpont Hodmezovasarhely-Mako" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator and "Quintiles, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.
Created with Highcharts 11.1.0Top Leading SponsorsBayer: 2Bayer: 2Boehringer Ingelheim: 2Boehringer Ingelheim: 2Pfizer's Upjohn hasmerged with Mylan toform Viatris Inc.: 2Pfizer's Upjohn hasmerged with Mylan toform Viatris Inc.: 2Daiichi Sankyo, Inc.: 1Daiichi Sankyo, Inc.: 1

Created with Highcharts 11.1.0Top CollaboratorsEli Lilly and Company: 2Eli Lilly and Company: 2Quintiles, Inc.: 1Quintiles, Inc.: 1

Clinical Trials Conditions at Csongrad Megyei Egeszsegugyi Ellato Kozpont Hodmezovasarhely-Mako


According to Clinical.Site data, the most researched conditions in "Csongrad Megyei Egeszsegugyi Ellato Kozpont Hodmezovasarhely-Mako" are "Atrial Fibrillation" (1 trials), "Diabetes Mellitus, Type 2" (1 trials), "End-stage Renal Disease" (1 trials), "Epilepsies, Partial" (1 trials) and "Generalized Tonic Clonic Seizures" (1 trials). Many other conditions were trialed in "Csongrad Megyei Egeszsegugyi Ellato Kozpont Hodmezovasarhely-Mako" in a lesser frequency.

Clinical Trials Intervention Types at Csongrad Megyei Egeszsegugyi Ellato Kozpont Hodmezovasarhely-Mako


Most popular intervention types in "Csongrad Megyei Egeszsegugyi Ellato Kozpont Hodmezovasarhely-Mako" are "Drug" (7 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "BAY1213790 (Osocimab)" (1 trials), "Edoxaban" (1 trials), "Empagliflozin" (1 trials) and "Finerenone (BAY94-8862)" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Csongrad Megyei Egeszsegugyi Ellato Kozpont Hodmezovasarhely-Mako


The vast majority of trials in "Csongrad Megyei Egeszsegugyi Ellato Kozpont Hodmezovasarhely-Mako" are 7 trials for "All" genders.

Clinical Trials Status at Csongrad Megyei Egeszsegugyi Ellato Kozpont Hodmezovasarhely-Mako


Currently, there are NaN active trials in "Csongrad Megyei Egeszsegugyi Ellato Kozpont Hodmezovasarhely-Mako". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Csongrad Megyei Egeszsegugyi Ellato Kozpont Hodmezovasarhely-Mako, undefined suspended trials, and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Csongrad Megyei Egeszsegugyi Ellato Kozpont Hodmezovasarhely-Mako, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 3Phase 3: 3Phase 4: 2Phase 4: 2Not Applicable: 1Not Applicable: 1Phase 2: 1Phase 2: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 5Completed: 5Active, not recruiting: 2Active, not recruiting: 2